Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials (Q34110004)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Neal W Wilkinson

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Greg Yothers

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Samia Lopa

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Joseph P Costantino

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Nicholas J Petrelli

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Norman Wolmark

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

959-966

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935319

5 July 2018

Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935319

5 July 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935319

5 July 2018

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935319

5 July 2018

End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935319

5 July 2018

Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935319

5 July 2018

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935319

5 July 2018

Fluorinated pyrimidines, a new class of tumour-inhibitory compounds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935319

5 July 2018

Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935319

28 October 2018

Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935319

28 October 2018

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935319

28 October 2018

Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935319

28 October 2018

Quantitating the impact of stage migration on staging accuracy in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20082144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20082144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant

1 reference

https://pubmed.ncbi.nlm.nih.gov/20082144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01

1 reference

https://pubmed.ncbi.nlm.nih.gov/20082144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02

1 reference

https://pubmed.ncbi.nlm.nih.gov/20082144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03

1 reference

https://pubmed.ncbi.nlm.nih.gov/20082144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Some considerations concerning the dose and schedule of 5FU and leucovorin: toxicities of two dose schedules from the intergroup colon adjuvant trial (INT-0089)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20082144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report

1 reference

https://pubmed.ncbi.nlm.nih.gov/20082144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20082144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant therapy for colon cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20082144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20082144

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1245/S10434-009-0881-Y

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34110004&oldid=2196262717"